Satoru Kusunoki
Directeur/Membre du Conseil chez Life Science Institute, Inc.
Provenance du réseau au premier degré de Satoru Kusunoki
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Life Science Institute, Inc.
 Life Science Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Life Science Institute, Inc. provides clinical testing and pharmaceutical development support activities. The company is headquartered in Tokyo, Japan.
7
| Subsidiary | Miscellaneous Commercial Services | 7 |
LSI Medience Corp.
 LSI Medience Corp. Medical SpecialtiesHealth Technology LSI Medience Corp. engages in the clinical examination business. It also engages in the diagnostic agent and drug discovery support business. The company was founded on April 1, 2014 and is headquartered in Tokyo, Japan.
4
| Subsidiary | Medical Specialties | 4 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Satoru Kusunoki via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| MITSUBISHI TANABE PHARMA CORPORATION | Pharmaceuticals: Other | Corporate Officer/Principal Director/Board Member | |
Mitsubishi Chemical Advanced Materials AG
 Mitsubishi Chemical Advanced Materials AG Miscellaneous Commercial ServicesCommercial Services Mitsubishi Chemical Advanced Materials AG engages in the manufacture of thermoplastic materials. It offers machine plastic parts, injection molded solutions, composite material, life science grades, and cable protection systems. The company was founded by René-Pierre Muller and Arno Schenk in 1996 and is headquartered in Zurich, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
| MITSUBISHI CHEMICAL GROUP CORPORATION | Chemicals: Major Diversified | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
PHC Corp.
 PHC Corp. Medical SpecialtiesHealth Technology PHC Corporation engages in the development, manufacture, sale and service of medical devices, and healthcare information technology (IT) and life sciences. It carries the business brands Medicom and PHCbi. The company was founded on November 21, 1969 and is headquartered in Tokyo, Japan. | Medical Specialties | Director/Board Member | |
API Corp.
 API Corp. Pharmaceuticals: MajorHealth Technology API Corp. engages in the manufacture and sale of drug substances, pharmaceutical formulation intermediates, investigational drug manufacturing and others. The company was founded in 2002 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Director/Board Member President Director/Board Member | |
Qualicaps Co., Ltd.
 Qualicaps Co., Ltd. Pharmaceuticals: MajorHealth Technology Qualicaps Co., Ltd. manufactures and markets hard gelatin and HPMC capsules, capsule filling equipment, and sealing machinery. Its products include pharmaceutical and health food capsules, capsule filling machines, capsule filling machine auger type, capsule weight inspection machine, laser imprinting system, and tablet imprinting machine. The company was founded on April 26, 1965 and is headquartered in Yamatokoriyama, Japan. | Pharmaceuticals: Major | Director/Board Member | |
| Kobe University | College/University | Masters Business Admin | |
| Nagoya University | College/University | Doctorate Degree | |
| Kyoto Pharmaceutical University | College/University | Graduate Degree | |
The Kaiteki Institute, Inc.
 The Kaiteki Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The Kaiteki Institute, Inc. engages in the research and investigation of social trends. It also involves in the research and development of new enterprises and operation and management of contract research. The company was founded on April 1, 2009 and is headquartered in Tokyo, Japan. | Miscellaneous Commercial Services | Director/Board Member | |
| PHC HOLDINGS CORPORATION | Medical Specialties | Director/Board Member Director/Board Member | |
Clio, Inc. (Japan)
 Clio, Inc. (Japan) BiotechnologyHealth Technology Clio, Inc. focuses on the advancement of regenerative medicine through the development of muse cells. It engages in the development of multilineage-differentiating stress-enduring cells, which are human-derived, pluripotent stem cells. The company was founded in December 2009 and is headquartered in Tokyo, Japan. | Biotechnology | Chief Executive Officer |
Statistiques
Internationale
| Japon | 11 |
| Canada | 2 |
| Suisse | 2 |
| Etats-Unis | 2 |
Sectorielle
| Health Technology | 8 |
| Consumer Services | 4 |
| Commercial Services | 3 |
| Process Industries | 2 |
Opérationnelle
| Director/Board Member | 21 |
| Corporate Officer/Principal | 7 |
| President | 5 |
| Chief Executive Officer | 3 |
| Masters Business Admin | 1 |
Relations les plus connectées
- Bourse
- Insiders
- Satoru Kusunoki
- Connexions Sociétés
